The usefulness of psychophysiology in the maintenance of cognitive life.

N. Bechtereva

DOI: https://doi.org/10.1016/j.ijpsycho.2008.03.016

IF: 2.903

2008-09-01

International Journal of Psychophysiology

Abstract:

What problem does this paper attempt to address?

Pulmonary alveolar proteinosis in China: a systematic review of 241 cases.

Zhihao Xu,Jiyong Jing,Huiying Wang,Feng Xu,Jiaoli Wang

DOI: https://doi.org/10.1111/j.1440-1843.2009.01539.x

IF: 6.9

2009-01-01

Respirology

Abstract:Background and objective: Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease. It was first described in China in 1965, and more cases have been reported subsequently. A systematic review was performed on 241 cases of PAP in China and progress in the diagnosis and treatment of this disease is discussed. Methods: The Chinese biological and medical databases from 1965 to 2006 were searched and 241 cases with complete clinical and pathological data were identified. The clinical characteristics of the disease were summarized and longitudinal comparisons were made of diagnostic and treatment methods over time. Results: The morbidity associated with PAP has increased in recent years. The clinical manifestations were non-specific. Progressive dyspnoea, cough and sputum were the most common symptoms. The percentage of patients undergoing CT examination has increased over the years. The combination of bronchoscopic biopsy and bronchoalveolar lavage (BAL) was usually sufficient to establish the diagnosis. Treatment was reported for a total of 142 cases. BAL and whole lung lavage were both effective and were only required once by most patients. Conclusions: The demographic characteristics and clinical manifestations of PAP patients in China are largely consistent with previous reports. Morbidity has increased dramatically in recent years, mainly due to the broad application of bronchoscopy since 1995. CT is very important for diagnosis of the disease. The long-term effects of treatment by whole lung lavage and BAL are similar.
Pulmonary Alveolar Proteinosis in China: A Systematic Review of 241 Cases

Zhihao Xu,Jiyong Jing,Huiying Wang,Feng Xu,Jiaoli Wang

DOI: https://doi.org/10.1111/j.1440-1843.2009.01539.x

2009-01-01

Abstract:Background and objective: Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease. It was first described in China in 1965, and more cases have been reported subsequently. A systematic review was performed on 241 cases of PAP in China and progress in the diagnosis and treatment of this disease is discussed.
Clinical features of pulmonary alveolar proteinosis: experience with 12 cases and literature review

HUANG Qiang,YING Kejing,DENG Zaichun

DOI: https://doi.org/10.3969/j.issn.1672-3686.2007.04.011

2007-01-01

Abstract:Objective To analyze and evaluate clinical features, pathological characteristics, diagnosis and treatment of the identified pulmonary alveolar proteinosis (PAP) patients.Methods Retrospective study of 12 patients identified by biopsy through BALF was conducted. Focused analysis with imaging studies (chest x-ray or CT/HRCT) and clinical presentations were aimed to determine the diagnostic methods of PAP. Results Nonspecific clinical representation of PAP was composed of progressive dyspnea (100%) and nonproductive cough (91.67%). Physical examination showed signs of inner lungsawas seldom detected, such as inspiratory crackles or Velcro's rales (41.67%) and cyanosis (25%). Although, absence of specific chest X-ray findings, some typical radiological changes contributed to diagnose PAP correctly, such as patchy opacification(91.67%)and crazy paving pattern(50%), especially in HRCT. Conclusion Separability of clinical symptoms and signs, radiological results and clinical features exist as characteristic representation of PAP. Diagnostic bronchoalveolar lavage is a practical and useful technology to determine PAP.
Large-volume Whole Lung Lavage in the Treatment of Severe Pulmonary Alveolar Proteinosis

Sheng-Lan Wen,Xiao-Hong Wu,Ke-Jing Ying,Pan Zhou,Wu-Jun Hong

DOI: https://doi.org/10.3760/j:issn:1001-0939.2004.09.006

2004-01-01

Abstract:OBJECTIVE:To evaluate the efficacy and safety of large-volume whole lung lavage in the treatment of severe pulmonary alveolar proteinosis (PAP).METHODS:Five severe PAP patients underwent large-volume whole lung lavage under general anaesthesia using a double lumen endotracheal tube. Suction was used for returning fluid. The volume of lavage and return volume and the return rate were calculated. The efficacy was evaluated according to the improvement of symptoms, amelioration of chest radiograph or chest CT scan and the changes of pulmonary function and artery blood gas analysis.RESULTS:After lavage, the symptoms, pulmonary function and artery blood gas were markedly improved, and the chest radiographs showed dissipation of lung consolidation. No severe complications were observed in the 5 cases.CONCLUSION:Large-volume whole lung lavage is an effective and safe therapeutic method in the treatment of PAP.
The Ultrastructrual Observation of Pulmonary Alveolar Proteinosis

Ming Chen

2002-01-01

Abstract:The pulmonary alveolar proteinosis (PAP) is a kind of causally unknown and infrequent pulmonary diseases. The pathologic feature is that the phospholipoprotein like surfactant, positive while dyed with periodic acid schiff has excessively accumulated in the alveoli cavity and the terminus of the bronchus. In this article, we selected five patients who have probably caught PAP. Vitally examed with the micro bronchoscope,their pulmonary tissue were taken,the ultra thin sections were observed by TEM. Two of these five patients could be excluded from catching PAP and the cellular ultrastructural alteration of the rest was fundamentally the same and corresponded with the pathologic alteration of the pulmonary tissue of PAP. The cellular ultrastructural feature of PAP is that of the typeⅡovergrown of alveolar epithelial cell and the abundence of that cellular chips, pulmonary surfactant, protein like structures and a number of spumous alveolar macrophages in the alveoli cavity and the terminus of the bronchus. The aboundance of these substances lead to the depression of the alveolar function and render the patients dyspnoea. The alteration of these ultrastructures sometimes is difficult to find with the LM. The use of the EM can help greatly in the clinical diagnosis.
The Foggy Lungs: A Case Report on Pulmonary Alveolar Proteinosis

Gokul Paidi,Jugroop S Brar,Andrea S Vizcaino Duran,Jose Benero-Fossatti,Anhad Brar,Farrah P Aziz Greye

DOI: https://doi.org/10.7759/cureus.38150

2023-04-26

Cureus

Abstract:Pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease characterized by macrophage dysfunction leading to the accumulation of surfactant in the alveoli and bronchiolar spaces, leading to impaired gas exchange and severe hypoxemia. The underlying mechanisms of PAP are not fully understood, but it is believed to involve impaired clearance of surfactant and abnormal immune responses. Diagnosis of PAP typically involves imaging studies and bronchoscopy, and treatment options include whole-lung lavage, pharmacotherapy, and lung transplantation. We report PAP in a 56-year-old female who worked in a dental office and had no prior diagnosis of lung disease.
Whole lung lavage in pulmonary alveolar proteinosis: anesthetic management and challenges

Manisha Manohar,Priyanka Bansal

DOI: https://doi.org/10.1186/s42077-022-00213-6

2022-02-05

Abstract:Abstract Background Pulmonary alveolar proteinosis is a rare disorder characterized by alveolar obstruction secondary to the collection of lipoproteinaceous material in the alveoli leading to a spectrum of respiratory illness ranging from mild to severe respiratory failure. Whole lung lavage considered the gold standard for the treatment of PAP is performed under general anesthesia and presents a unique set of challenges to the anesthesiologist. The procedure involves manually removing the lipoproteinacious material by repeating aliquots of fluids and draining periodically after percussion. When done effectively it is quite effective and life-saving procedure. Case presentation A 39-year-old female presented with history of gradually progressive shortness of breath, diagnosed to have primary pulmonary alveolar proteinosis for which bilateral whole lung lavage was planned. During the lavage cycles, patient had episodes of desaturation to 60% during which the double lung ventilation was resumed. Her serial ABG revealed a deteriorating oxygenation. In view of increased oxygen requirements, the procedure was carried out in two stages. She made a complete recovery after the procedure. Conclusions A multidisciplinary team working with good communication, use of adequate back up plans, meticulous lung separation with double lumen tube, vigilant intraoperative monitoring, short-term postoperative ventilation go a long way in achieving adequate gas exchange in patients with respiratory failure due to pulmonary alveolar proteinosis.
Clinical Review of 17 Cases with Pulmonary Alveolar Proteinosis

XIE Weijian,BAI Chunxue

DOI: https://doi.org/10.3969/j.issn.1008-6358.2006.04.023

2006-01-01

Abstract:Objective:To improve the understanding of the diagnosis and treatment of pulmonary alveolar proteinosis(PAP). Methods: A retrospective analysis of 17 cases who were diagnosed of PAP with pathological evidences from June 1996 to February 2006 was made. Results: There were 14 cases had significant improvement in clinical manifestation, chest CT scan, ABG and pulmonary function tests. Conclusion:PAP may a clinical manifestation of cough progressing dyspnea and lowered breath sound. Chest X-ray of ten shows a diffuse ground glass pattern of both lungs with patches nodules or reticular infiltrates CT scan demonstrates map-like patches with a pavestone pattern. The diagnosis should be made with pathological evidences. Upto -date, the only effective treatment is bronchoalveolar lavage.
[Pulmonary Alveolar Proteinosis: a Report of 2 Cases, with Literature Review].

Zhan-cheng Gao,Qing Xue,Yu Xu,Yin-ping Li,Dan-hua Shen,Quan-ying He

DOI: https://doi.org/10.3760/j.issn:1003-0603.2003.07.011

2003-01-01

Abstract:OBJECTIVE:To summarize and analyze the clinical manifestations of pulmonary alveolar proteinosis (PAP) and its treatment.METHODS:Retrospective analysis of 2 cases with literature was reviewed.RESULTS:PAP presented a protracted chronic clinical course with overt symptoms but few physical signs, distinct chest radiography, and was a benign process. It was manifested as primary or secondary pathological changes. Typical chest CT scan showed "map" or "cobble stone" changes. Clinically, PAP was characterized by its incompatibility between symptoms and signs, and also radiographic picture and physical signs. The examination of bronchoalveolar lavage fluid could be used to confirm the diagnosis of PAP with periodic acid-schiff staining and electro microscopic examination. Whole lung lavage was an efficient therapy for PAP.CONCLUSION:It is very important for physicians to pay much more attention on the early diagnosis and treatment of pulmonary alveolar proteinosis.
Therapeutic limited bronchoalveolar lavage with fiberoptic bronchoscopy as a bridging procedure prior to total lung lavage in a patient with pulmonary alveolar proteinosis: a case report

Damith Rodrigo,Amila Rathnapala,Wijitha Senaratne

DOI: https://doi.org/10.1186/s13256-015-0574-z

2015-04-29

Abstract:Introduction: Therapeutic total lung lavage under general anesthesia is the current mainstay of treatment for pulmonary alveolar proteinosis, which is a rare lung disease characterized by alveolar accumulation of surfactant. Therapeutic limited bronchoalveolar lavage is considered an alternative treatment to conventional total lung lavage. Case presentation: A 61-year-old, previously healthy, Sri Lankan Moor woman presented to our facility with progressively worsening difficulty in breathing and persistent dry cough for one year. Her respiratory examination revealed bibasal fine end-inspiratory crepitations. A chest radiograph showed bilateral mid and lower zone alveolar interstitial shadows and a high-resolution computed tomography scan of her chest revealed septal thickening with ground-glass shadows more on mid and lower zones bilaterally. A diagnostic bronchoalveolar lavage fluid analysis revealed diastase-resistant protein clumps in periodic acid Schiff stain. The diagnosis was made as pulmonary alveolar proteinosis. An arterial blood gas analysis performed prior to intervention revealed a significant hypoxia (partial pressure of oxygen - 64 mmHg) with alveolar-arterial gradient was 35.4 mmHg. Therapeutic limited bronchoalveolar lavage was arranged and her right and her left lung were lavaged separately in two sessions done two weeks apart under local anesthesia. Our patient had significant clinical improvement and resolution of the bilateral septal thickening with minimal resolution of the ground-glass opacities in a repeat high-resolution computed tomography scan done two weeks later. Subsequently, a total lung lavage under general anesthesia was also done, which improved her dyspnea and arterial hypoxemia. Conclusions: Therapeutic limited bronchoalveolar lavage can be successfully performed as an interval bridging procedure, as a 'prewash', prior to conventional total lung lavage for pulmonary alveolar proteinosis.
European Respiratory Society guidelines for the Diagnosis and Management of Pulmonary Alveolar Proteinosis

Cormac McCarthy,Francesco Bonella,Marissa O'Callaghan,Clairelyne Dupin,Tiago Alfaro,Markus Fally,Raphael Borie,Ilaria Campo,Vincent Cottin,Aurelie Fabre,Matthias Griese,Alice Hadchouel,Stephane Jouneau,Maria Kokosi,Effrosyni Manali,Helmut Prosch,Bruce Trapnell,Marcel Veltkamp,Tisha Wang,Ingrid Toews,Alexander Mathioudakis,Elisabeth Bendstrup

DOI: https://doi.org/10.1183/13993003.00725-2024

2024-08-15

Abstract:Background: Pulmonary alveolar proteinosis (PAP) is a rare syndrome caused by several distinct diseases leading to progressive dyspnoea, hypoxemia, risk of respiratory failure and early death due to accumulation of proteinaceous material in the lungs. Diagnostic strategies may include computed tomography (CT) of the lungs, bronchoalveolar lavage, evaluation of antibodies against granulocyte macrophage colony stimulating factor (GM-CSF), genetic testing, and, eventually, lung biopsy. The management options are focused at removing the proteinaceous material by whole lung lavage (WLL), augmentation therapy with GM-CSF, rituximab, plasmapheresis, and lung transplantation. The presented diagnostic and management guideline aim to provide guidance to physicians managing patients with PAP. Methods: A European Respiratory Society Task Force committee composed of clinicians, methodologists, and patients with experience in PAP developed recommendations in accordance with the ERS Handbook for Clinical Practice Guidelines and the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) approach. This included a systematic review of the literature and application of the GRADE approach to assess the certainty of the evidence and strength of recommendations. The committee formulated five PICO (Patients, Intervention, Comparison, Outcomes) questions, and two narrative questions to develop specific evidence-based recommendations. Results: The Task Force committee developed recommendations for five PICOs. These included management of PAP with WLL, GM-CSF augmentation therapy, rituximab, plasmapheresis, and lung transplantation. Also, the committee made recommendations regarding the use of GM-CSF antibody testing, diagnostic bronchoalveolar lavage (BAL) and biopsy based on narrative questions.In addition to the recommendations, the committee provided information on the hierarchy of diagnostic interventions and therapy. Conclusions: The diagnosis of PAP is based on CT and BAL cytology or lung histology, whereas diagnosis of specific PAP-causing diseases requires GM-CSF antibody testing or genetic analysis. There are several therapies including WLL and augmentation therapy with GM-CSF available to treat PAP, but supporting evidence is still limited.
How to do whole lung lavage for treatment of pulmonary alveolar proteinosis

Tovi Vo,Justin C. Y. Chan,Michael Worthington

DOI: https://doi.org/10.1111/ans.15769

IF: 1.7

2020-02-26

ANZ Journal of Surgery

Abstract:Pulmonary alveolar proteinosis is a rare condition characterized by progressive accumulation of surfactant lipoproteins in the alveolar space, leading to poor gas exchange. We describe our technique of whole lung lavage for management of pulmonary alveolar proteinosis.

surgery
Clopidogrel and burns: platelet replacement therapy may not prevent postoperative bleeding.

M. Feldman,G. Curinga,S. Milner

DOI: https://doi.org/10.1016/j.burns.2010.04.012

IF: 2.609

2010-11-01

Burns

Abstract:
[Pulmonary lavage for alveolar proteinosis. A case report]

C L Yang,K L Wong,K B Lai,M S Mok,T T Wei

Abstract:Pulmonary alveolar proteinosis is characterized by an amorphous lipoproteinaceous material filling the acini of the lung, resulting in hypoxemia. At present, the most effective treatment for alveolar proteinosis is lung lavage. Here, we report the first case in Taiwan treated with this method. A 38-year-old male with a 6-month history of cough and increasing breathlessness was transferred from another hospital. On admission, his arterial oxygen tension was 51 mmHg when breathing room air. Chest X-ray films showed diffuse infiltration of both lung fields. Transbronchoscopic lung biopsy was consistent with alveolar proteinosis, therefore the patient was submitted to pulmonary lavage. Under general anesthesia, the patient was intubated with a left-sided double lumen endotracheal tube, and lavage of the right lung was repeated with 0.9% saline until the washing became clear. At the end of the procedure, the patient was extubated after making strong respiratory efforts. Several days later, the left lung was lavaged using the same technique. The mechanical washing of amorphous material from alveoli by pulmonary lavage is of great benefit in relieving hypoxemia. Judicious use of lung lavage is effective and safe for patient with alveolar proteinosis.
A Case Report of Pulmonary Alveolar Proteinosis Masquerading as Respiratory Distress Syndrome in Preterm Neonates

Aditi Rawat,Sagar Karotkar,Mahaveer S Lakra,Snehlata Hingway,Revatdhamma Meshram,Amar Taksande

DOI: https://doi.org/10.7759/cureus.63866

2024-07-04

Cureus

Abstract:A rare and challenging case of a preterm neonate with clinical and radiological signs of respiratory distress syndrome (RDS) since the first hour of life but was refractory to its standard treatment regimes like surfactant therapy and ventilation. Postmortem lung biopsy led us to the diagnosis of congenital pulmonary alveolar proteinosis (PAP). It occurs due to the aggregation of abnormal surfactant proteins and lipids in the alveoli, which hampers gas diffusion across the alveoli. It presents as respiratory distress at birth, and its diagnosis is often missed due to its resemblance with RDS. Although the exact etiology remains elusive, mutations in genes encoding surfactant and granulocyte-macrophage colony-stimulating factor (GM-CSF) pathway components have been implicated in the pathogenesis of PAP. Treatment options are limited and only supportive. Among all these, whole-lung lavage is the most widely used management modality but with limited success in neonates.
[Congenital pulmonary alveolar proteinosis in a neonate].

Jun-Yan Han,Rong Zhang,Jian-Guo Zhou,Li-Yuan Hu,Li-Ling Qian,Ai-Zhen Lu,Lin Yang,Yang-Yang Ma,Zhong-Wei Qiao,Lan Zhang

DOI: https://doi.org/10.7499/j.issn.1008-8830.2307035

2023-01-01

Abstract:The male patient was referred to the hospital at 44 days old due to dyspnea after birth and inability to wean off oxygen. His brother died three days after birth due to respiratory failure. The main symptoms observed were respiratory failure, dyspnea, and hypoxemia. A chest CT scan revealed characteristic reduced opacity in both lungs with a "crazy-paving" appearance. The bronchoalveolar lavage fluid (BALF) showed periodic acid-Schiff positive proteinaceous deposits. Genetic testing indicated a compound heterozygous mutation in the gene. The diagnosis for the infant was congenital pulmonary alveolar proteinosis (PAP). Congenital PAP is a significant cause of challenging-to-treat respiratory failure in full-term infants. Therefore, congenital PAP should be considered in infants experiencing persistently difficult-to-treat dyspnea shortly after birth. Early utilization of chest CT scans, BALF pathological examination, and genetic testing may aid in early diagnosis.
[Idiopathic Pulmonary Alveolar Proteinosis: Report of Three Cases and Literature Review].

Xiang-dong Mu,Li-gong Nie,Guang-fa Wang,Cheng-li Que,Hai-chao Li

DOI: https://doi.org/10.3321/j.issn:1671-167x.2008.05.022

2008-01-01

Abstract:To describe the clinical, radiological and pathological characteristics of idiopathic pulmonary alveolar proteinosis (I-PAP) and to evaluate the methods of diagnosis and treatment. Three patients were successfully diagnosed and treated in our hospital and the literature on the subject was reviewed. Three patients, two males and one female (mean age 46 years), were diagnosed averagely in 4 months. Two severe patients presented with progressive dyspnea and type I respiratory failure, and one mild patient only with dry cough and hypoxemia. Chest X-ray radiographs all showed perihilar "butterfly" shadow and chest CT scans showed diffused ground-glass opacities (GGO), typically with "map" changes and "crazy paving" patterns. All the patients underwent bronchoscope, branchoalveolar lavage fluid (BALF) had grossly opaque and/or milky appearance and its sediment was periodic acid-Schiff stain positive. Trans-bronchoscopic lung biopsy (TBLB) specimens were obtained and under light microscopy alveoli and some of the small bronchioles were filled with eosinophilic proteinaceous material with needle-like clefts. By electron microscopy numerous cellular debris and extracellular multilamellated bodies were found. Two severe patients were successfully treated with sequential whole-lung lavage and one required repeated lavages. I-PAP is rare and prone to be misdiagnosed. The radiological features may indicate the diagnosis and examinations of TBLB and BALF can make the accurate diagnosis. Whole-lung lavage is the most effective therapy by now and granulocyte-macrophage colony-stimulating factor (GM-CSF) may be beneficial in some patients.
Alveolar Macrophages in Pulmonary Alveolar Proteinosis: Origin, Function, and Therapeutic Strategies

Xinmei Huang,Mengshu Cao,Yonglong Xiao

DOI: https://doi.org/10.3389/fimmu.2023.1195988

IF: 7.3

2023-01-01

Frontiers in Immunology

Abstract:Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder that is characterized by the abnormal accumulation of surfactant within the alveoli. Alveolar macrophages (AMs) have been identified as playing a pivotal role in the pathogenesis of PAP. In most of PAP cases, the disease is triggered by impaired cholesterol clearance in AMs that depend on granulocyte-macrophage colony-stimulating factor (GM-CSF), resulting in defective alveolar surfactant clearance and disruption of pulmonary homeostasis. Currently, novel pathogenesis-based therapies are being developed that target the GM-CSF signaling, cholesterol homeostasis, and immune modulation of AMs. In this review, we summarize the origin and functional role of AMs in PAP, as well as the latest therapeutic strategies aimed at addressing this disease. Our goal is to provide new perspectives and insights into the pathogenesis of PAP, and thereby identify promising new treatments for this disease.
Diagnosis and Differentiated Diagnosis of Pulmonary Alveolar Proteinosis

CHEN Peirong,CAI Hourong

DOI: https://doi.org/10.3969/j.issn.1009-6663.2005.03.023

2005-01-01

Abstract:Objective To analyze ways that diagnosis and differentiated diagnosis are made on pulmonary alreolar proteinosis. Methods The data of 8 cases of pulmonary alreolar proteinosis were analyzed, including the results from chest X-rays and CT examinations (including HRCT). Results The X-rays and CT results varied. HRCT indicated the changes of lung marking and crazy paving appearance. Conclusion A careful examination of characterisitcs of X-rays and CT, combined with clinical symptoms, should be conducted in order to make the accurate diagnosis.
Single Lung Transplantation for Idiopathic Pulmonary Alveolar Proteinosis with Intraoperative Veno-Venous Extracorporeal Membrane Oxygenation Support

Jialong Liang,Yuan Chen,Mingfeng Zheng,Shugao Ye,Feng Liu,Jingyu Chen,Yong Ji

DOI: https://doi.org/10.1016/j.trim.2022.101627

IF: 2.032

2022-01-01

Transplant Immunology

Abstract:Pulmonary alveolar proteinosis (PAP) is a rarely progressive disease. This disease is characterized by the accumulation of a large amount of pulmonary surfactant in the alveolar cavity and terminal bronchiole, which is caused by the obstruction of clearance due to the weakened function of alveolar macrophages in vivo. Idiopathic PAP(IPAP) is the most common type of PAP, accounting for about 90%, and its pathogenesis remains unclear. The treatments of PAP include whole lung lavage, inhaled/subcutaneous GM-CSF, rituximab, plasmapheresis and lung transplantation. We describe a patient with IPAP who is in good condition five years after undergoing a single lung transplantation(SLT). This is the first report of IPAP treated with SLT. Accourding to the previous report and the follow-up result, lung transplantation may be an effective long-term treatment for both secondary PAP and IPAP.

The usefulness of psychophysiology in the maintenance of cognitive life.

Pulmonary alveolar proteinosis in China: a systematic review of 241 cases.

Pulmonary Alveolar Proteinosis in China: A Systematic Review of 241 Cases

Clinical features of pulmonary alveolar proteinosis: experience with 12 cases and literature review

Large-volume Whole Lung Lavage in the Treatment of Severe Pulmonary Alveolar Proteinosis

The Ultrastructrual Observation of Pulmonary Alveolar Proteinosis

The Foggy Lungs: A Case Report on Pulmonary Alveolar Proteinosis

Whole lung lavage in pulmonary alveolar proteinosis: anesthetic management and challenges

Clinical Review of 17 Cases with Pulmonary Alveolar Proteinosis

[Pulmonary Alveolar Proteinosis: a Report of 2 Cases, with Literature Review].

Therapeutic limited bronchoalveolar lavage with fiberoptic bronchoscopy as a bridging procedure prior to total lung lavage in a patient with pulmonary alveolar proteinosis: a case report

European Respiratory Society guidelines for the Diagnosis and Management of Pulmonary Alveolar Proteinosis

How to do whole lung lavage for treatment of pulmonary alveolar proteinosis

Clopidogrel and burns: platelet replacement therapy may not prevent postoperative bleeding.

[Pulmonary lavage for alveolar proteinosis. A case report]

A Case Report of Pulmonary Alveolar Proteinosis Masquerading as Respiratory Distress Syndrome in Preterm Neonates

[Congenital pulmonary alveolar proteinosis in a neonate].

[Idiopathic Pulmonary Alveolar Proteinosis: Report of Three Cases and Literature Review].

Alveolar Macrophages in Pulmonary Alveolar Proteinosis: Origin, Function, and Therapeutic Strategies

Diagnosis and Differentiated Diagnosis of Pulmonary Alveolar Proteinosis

Single Lung Transplantation for Idiopathic Pulmonary Alveolar Proteinosis with Intraoperative Veno-Venous Extracorporeal Membrane Oxygenation Support